Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

IFRX

IFRX News

Newswire

08:48

Leerink downgrades InflaRx to Market Perform from Outperform, PT $2.

23:01

InflaRx: Gohibic's Niche Position Fails to Impress, INF904 Underwhelms, Cash Burn Accelerates.

17:05

InflaRx shares surge 13.13% after-hours as Raymond James raises price target to $9 on positive HS trial data.

11:43

InflaRx shares jump 20.87% intraday after Raymond James and Cantor Fitzgerald raise price targets on positive HS trial data.

10:22

InflaRx shares surge 10.13% intraday as INF904 shows significant improvement in HS and CSU clinical trials.

View More

About IFRX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More